Lower riskDrug recall · FDA · Published May 14, 2020
InvaGen Gabapentin Tablets Recall: Impurity Risk in Long-Term Storage
InvaGen Pharmaceuticals recalls 600mg Gabapentin tablets due to impurity failure in long-term stability testing. Affected lots may pose risks if stored beyond expiration.
“InvaGen Gabapentin Tablets Recall: Impurity Risk in Long-Term Storage.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37119-invagen-gabapentin-tablets-recall-impurity-risk-in-long-term-storage. Based on FDA recall #D-1272-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1272-2020%22&limit=1).
InvaGen Pharmaceuticals, Inc. voluntarily recalled Gabapentin Tablets USP, 600 mg, manufactured for Exelan Pharmaceuticals, Inc., due to failed impurity specifications, the FDA announced on May 14, 2020. The recall affects 2,202 bottles distributed nationwide.
Manufacturer: InvaGen Pharmaceuticals, Inc., Hauppauge, NY 11788
Distributor: Exelan Pharmaceuticals, Inc., Lawrenceville, GA 30046
The hazard
The recall was initiated because the product failed Impurity A test at the 12-month long-term stability testing. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show InvaGen Pharmaceuticals, Inc. has had 7 other recalls on record since March 5, 2018. Other recent recalls of similar products include Somerset Therapeutics Dexamethasone Injection Recall (Feb. 4, 2026) and Sagent Busulfan Injection Recall (May 4, 2026).
How to tell if you have this one
Check for the NDC code 76282-405-05 on the bottle. The specific lot number NB900413 was manufactured in Lawrenceville, GA and expires December 2020.
Brand
InvaGen
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the NDC code 76282-405-05 and lot number NB900413 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 4 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1272-2020 (May 14, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1272-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.